ofa semaglutide lawsuit Files Another Against the FDA, This Time Over Novo Nordisk is dismissing its

Holding at a dose for an extra 4 weeks before escalating is a medically supported strategy when: Nausea or vomiting persists beyond 2 weeks at the current dose You are unable to eat at least 1,000 calories per day comfortably Dehydration symptoms appear (dark urine, dizziness on standing, dry mouth) You are losing weight faster than 1 to 2 pounds per week on the current dose (aggressive weight loss increases side effect risk) In the STEP trials, delayed escalation did not compromise overall weight loss outcomes at 68 weeks

The good news is that probiotics may help alleviate these issues while supporting your overall gut health

Injection site reactions occurred in 1.9-4.5% of tirzepatide recipients compared to just 0.2% of semaglutide recipients in the SURPASS-2 trial

2021 Wegovy (semaglutide) A pivotal moment in obesity treatment, demonstrating unprecedented weight-loss outcomes and changing both clinical practice and public perception